Retrospective clinical study on the notable efficacy and related factors of infliximab therapy in a rheumatoid arthritis management group in Japan : one-year outcome of joint destruction (RECONFIRM-2J)

  • TAKEUCHI Tsutomu
    Department of Rheumatology and Clinical Immunology, Saitama Medical Center, Saitama Medical University
  • YAMANAKA Hisashi
    Institute of Rheumatology, Tokyo Women's Medical University
  • INOUE Eisuke
    Institute of Rheumatology, Tokyo Women's Medical University
  • NAGASAWA Hayato
    Department of Rheumatology and Clinical Immunology, Saitama Medical Center, Saitama Medical University
  • NAWATA Masao
    The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health
  • IKARI Katsunori
    Institute of Rheumatology, Tokyo Women's Medical University
  • SAITO Kazuyoshi
    The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health
  • SEKIGUCHI Naoya
    Department of Rheumatology and Clinical Immunology, Saitama Medical Center, Saitama Medical University
  • SATO Eri
    Institute of Rheumatology, Tokyo Women's Medical University
  • KAMEDA Hideto
    Department of Rheumatology and Clinical Immunology, Saitama Medical Center, Saitama Medical University
  • IWATA Shigeru
    The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health
  • MOCHIZUKI Takeshi
    Institute of Rheumatology, Tokyo Women's Medical University
  • AMANO Kouichi
    The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health
  • TANAKA Yoshiya
    The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health

この論文をさがす

収録刊行物

被引用文献 (14)*注記

もっと見る

参考文献 (26)*注記

もっと見る

詳細情報

問題の指摘

ページトップへ